Unal B, Saatcioglu F (2025)
Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppression
Biomark Res, 13 (1), 156
DOI 10.1186/s40364-025-00813-y, PubMed 41372991

Høyvik AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, Peng Q, Wangen-Riise R, Wiig E, Ma LW, Revheim ME, Juzeniene A (2025)
Optimizing [²¹²Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts
J Nucl Med, 66 (12), 1956-1963
DOI 10.2967/jnumed.125.270444, PubMed 41043994

Amdal CD, Falk RS, Alanya A, Schlichting M, Roychoudhury S, Bhatnagar V, Wintner LM, Regnault A, Ingelgård A, Coens C, le Cessie S, Holzner B, Chang J, Taphoorn M, Cislo P, Giesinger JM, Cappelleri JC, Pawar V, Ten Seldam S, Papadopoulos EJ, Calvert MJ, Joseph KL, Bottomley A, Griebsch I, Arraras JI et al. (2025)
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials
Lancet Oncol, 26 (12), e683-e693
DOI 10.1016/S1470-2045(25)00520-0, PubMed 41308689